FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Lee Catherine Chai-zon
2. Issuer Name and Ticker or Trading Symbol

Metacrine, Inc. [ MTCR ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
EVP, Gen. Counsel & Secretary
(Last)          (First)          (Middle)

C/O METACRINE, INC., 3985 SORRENTO VALLEY BLVD.,SUITE C
3. Date of Earliest Transaction (MM/DD/YYYY)

5/5/2021
(Street)

SAN DIEGO, CA 92121
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 5/5/2021  A  3846 A (1)3846 D  

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares

Explanation of Responses:
(1) Although not required, the Reporting Person has elected to report 3,846 shares of Common Stock that were acquired by the Reporting Person on 5/5/2021 pursuant to the Issuer's Employee Stock Purchase Plan

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Lee Catherine Chai-zon
C/O METACRINE, INC.
3985 SORRENTO VALLEY BLVD.,SUITE C
SAN DIEGO, CA 92121


EVP, Gen. Counsel & Secretary

Signatures
/s/ Catherine C. Lee5/7/2021
**Signature of Reporting PersonDate

Metacrine (NASDAQ:MTCR)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Metacrine Charts.
Metacrine (NASDAQ:MTCR)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Metacrine Charts.